Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;42(6):e483-e487.
doi: 10.1097/MPH.0000000000001517.

A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease

Affiliations
Review

A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease

Anna M Caroleo et al. J Pediatr Hematol Oncol. 2020 Aug.

Abstract

The authors describe a newborn diagnosed with localized neuroblastoma that evolved to stage 4s at the age of 5 months. Peculiar features of the case included a bilateral adrenal primary, the skin as the only metastatic site, and the development of a muscular lesion late in the clinical course. The patient underwent left adrenalectomy and all other lesions regressed without further therapy. The case prompted a search for similar cases both in the Italian Neuroblastoma Registry and in the literature. All patients identified, although variously treated, survived with the exception of the 2 with MYCN gene amplification. We conclude that infants with neuroblastoma who undergo a transition from a localized to stage 4s disease could be less rare than expected. In the absence of unfavorable biology, a wait-and-see policy with strict follow-up could be adopted for these patients, avoiding potentially damaging systemic therapy.

PubMed Disclaimer

References

    1. Luksch R, Castellani MR, Collini P, et al. Neuroblastoma (peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163–181.
    1. De Bernardi B, Mosseri V, Rubie H, et al. Treatment of localized resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer. 2008;99:1027–1033.
    1. Hero B, Simon T, Spitz R, et al. Localized infant neuroblastoma often shows spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008;26:1504–1510.
    1. Rubie H, De Bernardi B, Gerrard M, et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol. 2011;29:449–455.
    1. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S disease neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Study Group. J Clin Oncol. 2000;18:477–486.